Table S1 from ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
Amir Arabzade(Baylor College of Medicine), Stephen C. Mack(St. Jude Children's Research Hospital), Yanhua Zhao(Jiangsu University), Minerva Solis(Baylor College of Medicine), Yuen San Chan(Baylor College of Medicine), Peter R. Wang(Rice University), Brian Golbourn(University of Pittsburgh), Kelsey C. Bertrand(University of Toronto), Baoli Hu(Shenyang University of Technology), Susan M. Blaney(Pediatrics and Genetics), Kathleen Kong(Baylor College of Medicine), Charles Y. Lin(Kronos Bios (United Kingdom)), Luz A. De León(Children's Cancer Center), Claudia L. Kleinman(Jewish General Hospital), Dana Tlais(Baylor College of Medicine), H. Courtney Hodges(Baylor College of Medicine), Kristen L. Karlin(Baylor College of Medicine), Thomas F. Westbrook(Baylor College of Medicine), Alisha Kardian(Baylor College of Medicine), Stefan M. Pfister(Heidelberg University), Madeline Ngo(Rice University), Srinidhi Varadharajan(Baylor College of Medicine), Sarah G. Injac(Baylor College of Medicine), Austin J. Stuckert(Baylor College of Medicine), Irtisha Singh(Texas A&M Health Science Center), Sameer Agnihotri(University of Pittsburgh), Bryan Rivas(Baylor College of Medicine), Ann-Catherine J. Stanton(Children's Hospital of Pittsburgh), Benjamin Deneen(Baylor College of Medicine), Robert Kupp(Cancer Research UK Cambridge Center), Felix Sahm(German Cancer Research Center), Daisuke Kawauchi(German Cancer Research Center), Selin Jessa(Stanford University), Nada Jabado(McGill University), Donald W. Parsons, Murali Chintagumpala(Baylor College of Medicine), Hsiao‐Chi Chen(Baylor College of Medicine), Richard J. Gilbertson(St. Jude Children's Research Hospital), Kristian W. Pajtler(German Cancer Research Center)
Cited by 0
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
|Cell|2009|1k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Challenges to curing primary brain tumours
|Nature Reviews Clinical Oncology|2019|965